# Evaluation of the EF192B Protection Versus No Treatment

> **NCT06752460** · NA · NOT_YET_RECRUITING · sponsor: **Eurofarma Laboratorios S.A.** · enrollment: 72 (estimated)

## Conditions studied

- Skin Lesions
- Skin Care

## Interventions

- **DEVICE:** EF192B

## Key facts

- **NCT ID:** NCT06752460
- **Lead sponsor:** Eurofarma Laboratorios S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08-31
- **Primary completion:** 2025-10-31
- **Final completion:** 2025-10-31
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2024-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06752460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06752460, "Evaluation of the EF192B Protection Versus No Treatment". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06752460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*